IL6 and hepatocellular carcinoma: As the gain in prognostic power by replacing CRP with IL-6 was minimal, and CRP is more widely available in clinical laboratories and more cost-effective, we consider the mGPS and ACR as the most clinically applicable score in patients with HCC.